Zeo ScientifiX, Inc.
For the period ended Oct 31, 2025. Filed Jan 29, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Jan 29, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ZEO SCIENTIFIX, INC. | |
| By: | /s/ Ian T. Bothwell |
| Ian T. Bothwell | |
| Chief Executive Officer, Chief Financial Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:
| Signature | Title | Date |
|---|---|---|
| /s/ Ian T. Bothwell | Chief Executive Officer, Chief Financial Officer, Director | January 29, 2026 |
| Ian T. Bothwell | (Principal Executive, Financial and Accounting Officer) | |
| /s/ George Shapiro | Chief Medical Officer, Director | January 29, 2026 |
| George Shapiro, M.D. | ||
| /s/ Chuck Bretz | Director and Chairman of the Board | January 29, 2026 |
| Chuck Bretz | ||
| /s/ Gurvinder Pal Singh | Director | January 29, 2026 |
| Gurvinder Pal Singh | ||
| /s/ S. Jerry Glauser | Director | January 29, 2026 |
| S. Jerry Glauser | ||
| /s/ Leathem Stearn | Director | January 29, 2026 |
| Leathem Stearn | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.